| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maria Angeles Peña-Toledo, Evelio Luque, Ignacio Ruz-Caracuel, Eduardo Agüera, Ignacio Jimena, Jose Peña-Amaro, Isaac Tune. Transcranial Magnetic Stimulation Improves Muscle Involvement in Experimental Autoimmune Encephalomyelitis. International journal of molecular sciences. vol 22. issue 16. 2021-09-15. PMID:34445295. |
eae was induced by injecting myelin oligodendrocyte glycoprotein (mog) into dark agouti rats. |
2021-09-15 |
2023-08-13 |
rat |
| Keita Takahashi, Hideyuki Takeuchi, Ryoko Fukai, Haruko Nakamura, Keisuke Morihara, Yuichi Higashiyama, Toshiyuki Takahashi, Hiroshi Doi, Fumiaki Tanak. Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment. Frontiers in immunology. vol 12. 2021-09-14. PMID:33659007. |
here we report three cases of anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) mimicking multiple sclerosis in which seropositivity for anti-mog antibodies occurred during disease-modifying drug dimethyl fumarate (dmf) treatment. |
2021-09-14 |
2023-08-13 |
Not clear |
| Andreas Wegener-Panzer, Robert Cleaveland, Eva-Maria Wendel, Matthias Baumann, Annikki Bertolini, Martin Häusler, Ellen Knierim, Edith Reiter-Fink, Markus Breu, Özcan Sönmez, Adela Della Marina, Renate Peters, Christian Lechner, Martin Piepkorn, Claudia Roll, Romana Höftberger, Frank Leypoldt, Markus Reindl, Kevin Rostás. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 4. 2021-09-13. PMID:32358225. |
to describe the presentations, radiologic features, and outcomes of children with autoimmune encephalitis associated with myelin oligodendrocyte glycoprotein antibodies (mog abs). |
2021-09-13 |
2023-08-13 |
Not clear |
| Ekaterina Esaulova, Claudia Cantoni, Irina Shchukina, Konstantin Zaitsev, Robert C Bucelli, Gregory F Wu, Maxim N Artyomov, Anne H Cross, Brian T Edelso. Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 4. 2021-09-13. PMID:32371549. |
to identify and characterize myeloid cell populations within the csf of patients with ms and anti-myelin oligodendrocyte glycoprotein (mog) disorder by high-resolution single-cell gene expression analysis. |
2021-09-13 |
2023-08-13 |
human |
| Melissa Grant-Peters, Giordani Rodrigues Dos Passos, Hing-Yuen Yeung, Anu Jacob, Saif Huda, Maria Isabel Leite, Calliope A Dendrou, Jacqueline Palac. No strong HLA association with MOG antibody disease in the UK population. Annals of clinical and translational neurology. vol 8. issue 7. 2021-09-07. PMID:33991459. |
improvements in assays for detecting serum antibodies against myelin oligodendrocyte glycoprotein (mog) have led to the appreciation of mog-antibody-associated disease (mogad) as a novel disorder. |
2021-09-07 |
2023-08-13 |
human |
| Sangam Shah, Rajeev Ojha, Sanjeeta Sitaula, Dosti Regmi, Ragesh Karn, Bikram Prasad Gajurel, Reema Rajbhandari, Niraj Gautam, Sunanda Paudel, Aashish Shresth. Recurrent Bilateral Optic Neuritis Associated with Myelin Oligodendrocyte Glycoprotein Antibody: A Case Report from Nepal. Case reports in neurological medicine. vol 2021. 2021-09-07. PMID:34484845. |
myelin oligodendrocyte glycoprotein (mog) expressed on the oligodendrocyte cell surface and on the outermost cell surface of the myelin sheath may also be present in patients with nmosd bilateral optic neuritis. |
2021-09-07 |
2023-08-13 |
Not clear |
| Wojciech Ambrosius, Sławomir Michalak, Wojciech Kozubski, Alicja Kalinowsk. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management. International journal of molecular sciences. vol 22. issue 1. 2021-09-06. PMID:33374173. |
myelin oligodendrocyte glycoprotein (mog)-associated disease (mogad) is a rare, antibody-mediated inflammatory demyelinating disorder of the central nervous system (cns) with various phenotypes starting from optic neuritis, via transverse myelitis to acute demyelinating encephalomyelitis (adem) and cortical encephalitis. |
2021-09-06 |
2023-08-13 |
Not clear |
| Jaya Sharma, M Tariq Bhatti, Helen V Danesh-Meye. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review. Clinical & experimental ophthalmology. vol 49. issue 2. 2021-08-31. PMID:33426799. |
myelin oligodendrocyte glycoprotein (mog)-igg associated disorder (mogad) is a distinct nosologic entity, which has been more recently described. |
2021-08-31 |
2023-08-13 |
Not clear |
| Maxton E Thoman, Susan C McKarn. Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery. Metabolites. vol 10. issue 9. 2021-08-30. PMID:32961928. |
pathogenic autoantibiotics that target the water channel aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) contribute to nmosd pathology. |
2021-08-30 |
2023-08-13 |
Not clear |
| Peng Bai, Meini Zhang, Jun Yuan, Runxiu Zhu, Na L. A comparison of the effects of rituximab versus other immunotherapies for MOG-IgG-associated central nervous system demyelination: A meta-analysis. Multiple sclerosis and related disorders. vol 53. 2021-08-24. PMID:34091176. |
myelin oligodendrocyte glycoprotein (mog) antibody disease (mog-ad) is now recognised as a nosological entity with specific clinical and paraclinical features to aid early diagnosis. |
2021-08-24 |
2023-08-13 |
Not clear |
| Yun-Feng Wang, Xue-Wu Liu, Jian-Ming Lin, Ji-Ye Liang, Xiu-He Zhao, Sheng-Jun Wan. The Clinical Features of FLAIR-Hyperintense Lesions in Anti-MOG Antibody Associated Cerebral Cortical Encephalitis with Seizures: Case Reports and Literature Review. Frontiers in immunology. vol 12. 2021-08-23. PMID:34177880. |
the presence of fluid attenuated inversion recovery (flair)-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated cerebral cortical encephalitis with seizures (flamces) was recently reported. |
2021-08-23 |
2023-08-13 |
Not clear |
| Krenar Veselaj, Nicole Kamber, Myriam Briner, Christoph Friedli, Lara Diem, Kirsten Guse, Andrei Miclea, Roland Wiest, Franca Wagner, Hilary Grabe, Mathias Abegg, Michael P Horn, Sandra Bigi, Andrew Chan, Robert Hoepner, Anke Salme. Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS neuroscience & therapeutics. vol 27. issue 4. 2021-08-18. PMID:33047894. |
myelin oligodendrocyte glycoprotein antibodies (mog-igg) have been proposed to define "mog encephalomyelitis" (mog-em), with published diagnostic and "red flag" criteria. |
2021-08-18 |
2023-08-13 |
Not clear |
| Solène Dauby, Dominique Dive, Laurence Lutteri, Cécile Andris, Isabelle Hansen, Pierre Maquet, Emilie Lommer. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort. Acta neurologica Belgica. 2021-08-17. PMID:34097296. |
to emphasize physio-pathological, clinical and prognosis differences between conditions causing serious and sometimes very similar clinical manifestations: anti-aquaporin-4 (aqp4) and anti-myelin oligodendrocyte glycoprotein (mog) antibodies related diseases, and seronegative nmosd (neuromyelitis optica spectrum disorders). |
2021-08-17 |
2023-08-13 |
Not clear |
| Romain Deschamps, Julie Pique, Xavier Ayrignac, Nicolas Collongues, Bertrand Audoin, Hélène Zéphir, Jonathan Ciron, Mikael Cohen, Jennifer Aboab, Guillaume Mathey, Nathalie Derache, David Laplaud, Eric Thouvenot, Bertrand Bourre, Aurélie Ruet, Françoise Durand-Dubief, Valérie Touitou, Catherine Vignal-Clermont, Caroline Papeix, Olivier Gout, Romain Marignier, Elisabeth Maillar. The long-term outcome of MOGAD: An observational national cohort study of 61 patients. European journal of neurology. vol 28. issue 5. 2021-08-12. PMID:33528851. |
the prognosis in myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a matter of debate. |
2021-08-12 |
2023-08-13 |
Not clear |
| Melanie Truong-Le, Bart Chwalis. Antibody Testing in Atypical Optic Neuritis. Seminars in ophthalmology. vol 35. issue 5-6. 2021-08-11. PMID:33150802. |
the last two decades have seen increasing recognition of atypical optic neuritis syndromes, driven in large part by characterization of demyelinating diseases associated with antibodies to aquaporin 4 (aqp4) and myelin oligodendrocyte glycoprotein (mog). |
2021-08-11 |
2023-08-13 |
Not clear |
| Kosuke Shimizu, Kazuki Agata, Shohei Takasugi, Shungo Goto, Yudai Narita, Tomohiro Asai, Yasuhiro Magata, Naoto Ok. New strategy for MS treatment with autoantigen-modified liposomes and their therapeutic effect. Journal of controlled release : official journal of the Controlled Release Society. vol 335. 2021-08-11. PMID:34033858. |
in these experiments, experimental autoimmune encephalomyelitis (eae) induced by autoantigenic myelin oligodendrocyte glycoprotein (mog) peptide was used as a model of primary progressive ms, and mog-modified liposomes encapsulating doxorubicin (mog-lipdox) were used as a therapeutic drug. |
2021-08-11 |
2023-08-13 |
mouse |
| Z-Z Ge, Y-B Wu, Z-Y Xue, K Zhang, R-X Zhan. The therapeutic effects of the peptidyl-prolyl cis/trans isomerase Pin1 inhibitor juglone on animal-model experimental autoimmune encephalomyelitis. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. vol 72. issue 2. 2021-08-11. PMID:34374656. |
eae was induced in c57bl/6 mice with myelin oligodendrocyte glycoprotein (mog) |
2021-08-11 |
2023-08-13 |
mouse |
| A García Ortega, F J Montañez Campos, S Muñoz, B Sanchez-Dalma. Autoimmune and demyelinating optic neuritis. Archivos de la Sociedad Espanola de Oftalmologia. vol 95. issue 8. 2021-08-05. PMID:32622510. |
finally, the latest insights into myelin oligodendrocyte glycoprotein (mog) disorders and chronic-recurring optic neuropathies (crion) are highlited. |
2021-08-05 |
2023-08-13 |
Not clear |
| Shengde Li, Haitao Ren, Yan Xu, Tao Xu, Yao Zhang, Hexiang Yin, Weihua Zhang, Jiuwei Li, Xiaotun Ren, Fang Fang, Wenhan Li, Yicheng Zhu, Bin Peng, Jing Wang, Yong Zhong, Liying Cu. Long-term efficacy of mycophenolate mofetil in myelin oligodendrocyte glycoprotein antibody-associated disorders: A prospective study. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 3. 2021-08-02. PMID:32170045. |
to investigate whether the use of mycophenolate mofetil (mmf) could reduce the relapse risk in patients with myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g (igg)-associated disorders (mogads). |
2021-08-02 |
2023-08-13 |
Not clear |
| Zheng Xu, Chun-Chieh Lin, Sophey Ho, George Vlad, Nicole Suciu-Foc. Suppression of Experimental Autoimmune Encephalomyelitis by ILT3.Fc. Journal of immunology (Baltimore, Md. : 1950). vol 206. issue 3. 2021-08-02. PMID:33361206. |
the murine model of ms is the experimental autoimmune encephalopathy (eae) induced by immunization of mice with myelin oligodendrocyte glycoprotein (mog) |
2021-08-02 |
2023-08-13 |
mouse |